Big Health has hired Kelvin Kwong, former director of product management at Jawbone, to be its vice president of product management. Big Health is currently focused on the sleep space with its app Sleepio, so it makes sense to hire a Jawbone vet -- the tracker company invested quite a bit in sleep tracking before its recent pivot toward medical devices.
Big Heath also announced the hire on Dr. Jenna Carl as medical director. Carl has worked at UCSF, Harvard Medical School, and the VA Palo Alto Health Care System.
“Big Health recognizes that cognitive behavioral technologies like Sleepio make overcoming insomnia accessible to anyone. The appointments of Kelvin Kwong and Dr. Carl will help Big Health stay at the forefront of this digital medicine revolution,” Colin Espie, cofounder of Big Health, said in a statement.
Welltok has appointed a new COO and president, Rob Scavo, the company announced last week. Phil Tamminga has been serving in the COO role since 2015; Welltok didn't discuss the reasons for Tamminga's departure in their release. Scavo most recently served as president of payer markets at TriZetto, and previously served at PacifiCare Health Systems and Andersen Consulting.
"Rob is a rare executive who has touched and managed nearly every aspect of a healthcare information technology and services business," Jeff Margolis, Welltok chairman and CEO, said in a statement. "He is an infectiously energetic leader, and will no doubt make a huge and immediate impact on exceeding customer expectations, motivating employees and building fruitful partnerships. Rob will continue to advance our industry-leading CaféWell Health Optimization Platform, as well as our advanced analytics and consumer engagement services to further our mission of creating a world where every healthcare consumer can achieve and sustain their optimal health."
CareMore has hired a new Chief Medical Officer to replace Dr. Sachin Jain, who was promoted to president of the organization last April. Dr. Zubin Eapen will take over the position, leading the development of novel clinical strategies and approaches to improve care. Eapen most recently served as Associate Professor of Medicine of the Division of Cardiology at Duke University.
“Dr. Eapen is a rare physician talent who combines a commitment to true clinical excellence with a passion for care redesign,” Jain said in a statement. “He will play a key role in driving the continued evolution of the CareMore model to better serve complex, high-cost, high-need patients--and bring a level of academic rigor to validating and improving upon our industry-leading clinical outcomes.”
Under Armour highlighted a few executive changes on its Q4 earnings call at the end of January. In mid-January the apparel company, which owns a stable of fitness and wellness apps, hired Lance Allega as VP of Investor Relations. In that role he "will be responsible for communicating Under Armour's growth strategy, financial performance, operating model, key business metrics and plans for building long-term shareholder value to investors, analysts and other external audiences" according to a statement from the company. In addition, on the call, CEO Kevin Plank noted that Under Armour CFO Chip Molloy would be leaving the company "for personal reasons".
"With this marking Chip's last call, I'd like to say thank you and wish him well in his future endeavors," Plank said. "Chip will continue to serve in an advisory role for a period of time."
Johnson & Johnson's medical device business has had a big shakeup, MedCityNews reports. Gary Pruden, worldwide chair of medical devices, has retired after 32 years on the job and Bridget Ross, the division's VP of commercial operations, has left the company after 28 years. Sandra Peterson, who already oversees other divisions at J&J, will add medical devices to her responsibilities, effectively replacing Pruden.
"Since joining the company more than four years ago, Sandi has been a valuable partner and has played a critical role in positioning Johnson & Johnson to thrive in a rapidly changing environment,” Alex Gorsky, chairman and CEO of Johnson & Johnson said in a statement. “Under Sandi’s leadership, our Consumer and Consumer Medical Device businesses have improved significantly, and the quality and efficiency of our operating infrastructure have been notably strengthened. Sandi has a proven track record and brings broad-based experience and a strategic, global perspective to our Hospital Medical Device business.”
Clarify Health Solutions has added Dr. Jack Cochran, former executive director of the Permanente Federation, to its board of directors. The San Francisco-based company uses AI and analytics to create a digital platform that helps guide patients through their care process.
"We are deeply grateful that Dr. Cochran is a believer in Clarify Health and is collaborating with us to improve healthcare delivery, first as a company advisor and now in an even more strategic role as a director on our board," Dr. Jean Drouin, CEO and co-founder of Clarify Health, said in a statement. "He shares our vision for leveraging advanced analytics to transform clinical operations, reduce costs, and most importantly, enhance patient experience. Dr. Cochran strengthens our leadership team because he understands how physicians think and operate—and has successfully overcome barriers to change in his past roles."